Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.

Identifieur interne : 000D62 ( PubMed/Curation ); précédent : 000D61; suivant : 000D63

Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.

Auteurs : Rahul Vijay [États-Unis] ; Xiaoyang Hua [États-Unis] ; David K. Meyerholz [États-Unis] ; Yoshimi Miki [Japon] ; Kei Yamamoto [Japon] ; Michael Gelb [États-Unis] ; Makoto Murakami [Japon] ; Stanley Perlman [États-Unis]

Source :

RBID : pubmed:26392224

Descripteurs français

English descriptors

Abstract

Oxidative stress and chronic low-grade inflammation in the lungs are associated with aging and may contribute to age-related immune dysfunction. To maintain lung homeostasis, chronic inflammation is countered by enhanced expression of proresolving/antiinflammatory factors. Here, we show that age-dependent increases of one such factor in the lungs, a phospholipase A2 (PLA2) group IID (PLA2G2D) with antiinflammatory properties, contributed to worse outcomes in mice infected with severe acute respiratory syndrome-coronavirus (SARS-CoV). Strikingly, infection of mice lacking PLA2G2D expression (Pla2g2d(-/-) mice) converted a uniformly lethal infection to a nonlethal one (>80% survival), subsequent to development of enhanced respiratory DC migration to the draining lymph nodes, augmented antivirus T cell responses, and diminished lung damage. We also observed similar effects in influenza A virus-infected middle-aged Pla2g2d(-/-) mice. Furthermore, oxidative stress, probably via lipid peroxidation, was found to induce PLA2G2D expression in mice and in human monocyte-derived macrophages. Thus, our results suggest that directed inhibition of a single inducible phospholipase, PLA2G2D, in the lungs of older patients with severe respiratory infections is potentially an attractive therapeutic intervention to restore immune function.

DOI: 10.1084/jem.20150632
PubMed: 26392224

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26392224

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.</title>
<author>
<name sortKey="Vijay, Rahul" sort="Vijay, Rahul" uniqKey="Vijay R" first="Rahul" last="Vijay">Rahul Vijay</name>
<affiliation wicri:level="2">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Iowa</region>
</placeName>
<wicri:cityArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hua, Xiaoyang" sort="Hua, Xiaoyang" uniqKey="Hua X" first="Xiaoyang" last="Hua">Xiaoyang Hua</name>
<affiliation wicri:level="2">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Iowa</region>
</placeName>
<wicri:cityArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Meyerholz, David K" sort="Meyerholz, David K" uniqKey="Meyerholz D" first="David K" last="Meyerholz">David K. Meyerholz</name>
<affiliation wicri:level="2">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Iowa</region>
</placeName>
<wicri:cityArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Miki, Yoshimi" sort="Miki, Yoshimi" uniqKey="Miki Y" first="Yoshimi" last="Miki">Yoshimi Miki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Kei" sort="Yamamoto, Kei" uniqKey="Yamamoto K" first="Kei" last="Yamamoto">Kei Yamamoto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gelb, Michael" sort="Gelb, Michael" uniqKey="Gelb M" first="Michael" last="Gelb">Michael Gelb</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195 Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195 Department of Chemistry and Department of Biochemistry, University of Washington, Seattle</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Murakami, Makoto" sort="Murakami, Makoto" uniqKey="Murakami M" first="Makoto" last="Murakami">Makoto Murakami</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Perlman, Stanley" sort="Perlman, Stanley" uniqKey="Perlman S" first="Stanley" last="Perlman">Stanley Perlman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Stanley-Perlman@uiowa.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26392224</idno>
<idno type="pmid">26392224</idno>
<idno type="doi">10.1084/jem.20150632</idno>
<idno type="wicri:Area/PubMed/Corpus">000D62</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D62</idno>
<idno type="wicri:Area/PubMed/Curation">000D62</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D62</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.</title>
<author>
<name sortKey="Vijay, Rahul" sort="Vijay, Rahul" uniqKey="Vijay R" first="Rahul" last="Vijay">Rahul Vijay</name>
<affiliation wicri:level="2">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Iowa</region>
</placeName>
<wicri:cityArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hua, Xiaoyang" sort="Hua, Xiaoyang" uniqKey="Hua X" first="Xiaoyang" last="Hua">Xiaoyang Hua</name>
<affiliation wicri:level="2">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Iowa</region>
</placeName>
<wicri:cityArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Meyerholz, David K" sort="Meyerholz, David K" uniqKey="Meyerholz D" first="David K" last="Meyerholz">David K. Meyerholz</name>
<affiliation wicri:level="2">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Iowa</region>
</placeName>
<wicri:cityArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Miki, Yoshimi" sort="Miki, Yoshimi" uniqKey="Miki Y" first="Yoshimi" last="Miki">Yoshimi Miki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Kei" sort="Yamamoto, Kei" uniqKey="Yamamoto K" first="Kei" last="Yamamoto">Kei Yamamoto</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gelb, Michael" sort="Gelb, Michael" uniqKey="Gelb M" first="Michael" last="Gelb">Michael Gelb</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195 Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195 Department of Chemistry and Department of Biochemistry, University of Washington, Seattle</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Murakami, Makoto" sort="Murakami, Makoto" uniqKey="Murakami M" first="Makoto" last="Murakami">Makoto Murakami</name>
<affiliation wicri:level="1">
<nlm:affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Perlman, Stanley" sort="Perlman, Stanley" uniqKey="Perlman S" first="Stanley" last="Perlman">Stanley Perlman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Stanley-Perlman@uiowa.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of experimental medicine</title>
<idno type="eISSN">1540-9538</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age Factors</term>
<term>Animals</term>
<term>CD11c Antigen (analysis)</term>
<term>Dendritic Cells (physiology)</term>
<term>Disease Susceptibility</term>
<term>Group II Phospholipases A2 (physiology)</term>
<term>Humans</term>
<term>Immunity, Innate</term>
<term>Lipids (analysis)</term>
<term>Lung (immunology)</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Oxidative Stress</term>
<term>Severe Acute Respiratory Syndrome (etiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules dendritiques (physiologie)</term>
<term>Facteurs de l'âge</term>
<term>Group II Phospholipases A2 (physiologie)</term>
<term>Humains</term>
<term>Immunité innée</term>
<term>Lipides (analyse)</term>
<term>Poumon (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Stress oxydatif</term>
<term>Susceptibilité à une maladie</term>
<term>Syndrome respiratoire aigu sévère (étiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>CD11c Antigen</term>
<term>Lipids</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Lipides</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Cellules dendritiques</term>
<term>Group II Phospholipases A2</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Dendritic Cells</term>
<term>Group II Phospholipases A2</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Age Factors</term>
<term>Animals</term>
<term>Disease Susceptibility</term>
<term>Humans</term>
<term>Immunity, Innate</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Facteurs de l'âge</term>
<term>Humains</term>
<term>Immunité innée</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Stress oxydatif</term>
<term>Susceptibilité à une maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Oxidative stress and chronic low-grade inflammation in the lungs are associated with aging and may contribute to age-related immune dysfunction. To maintain lung homeostasis, chronic inflammation is countered by enhanced expression of proresolving/antiinflammatory factors. Here, we show that age-dependent increases of one such factor in the lungs, a phospholipase A2 (PLA2) group IID (PLA2G2D) with antiinflammatory properties, contributed to worse outcomes in mice infected with severe acute respiratory syndrome-coronavirus (SARS-CoV). Strikingly, infection of mice lacking PLA2G2D expression (Pla2g2d(-/-) mice) converted a uniformly lethal infection to a nonlethal one (>80% survival), subsequent to development of enhanced respiratory DC migration to the draining lymph nodes, augmented antivirus T cell responses, and diminished lung damage. We also observed similar effects in influenza A virus-infected middle-aged Pla2g2d(-/-) mice. Furthermore, oxidative stress, probably via lipid peroxidation, was found to induce PLA2G2D expression in mice and in human monocyte-derived macrophages. Thus, our results suggest that directed inhibition of a single inducible phospholipase, PLA2G2D, in the lungs of older patients with severe respiratory infections is potentially an attractive therapeutic intervention to restore immune function. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26392224</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>02</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1540-9538</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>212</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
<Day>19</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of experimental medicine</Title>
<ISOAbbreviation>J. Exp. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.</ArticleTitle>
<Pagination>
<MedlinePgn>1851-68</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1084/jem.20150632</ELocationID>
<Abstract>
<AbstractText>Oxidative stress and chronic low-grade inflammation in the lungs are associated with aging and may contribute to age-related immune dysfunction. To maintain lung homeostasis, chronic inflammation is countered by enhanced expression of proresolving/antiinflammatory factors. Here, we show that age-dependent increases of one such factor in the lungs, a phospholipase A2 (PLA2) group IID (PLA2G2D) with antiinflammatory properties, contributed to worse outcomes in mice infected with severe acute respiratory syndrome-coronavirus (SARS-CoV). Strikingly, infection of mice lacking PLA2G2D expression (Pla2g2d(-/-) mice) converted a uniformly lethal infection to a nonlethal one (>80% survival), subsequent to development of enhanced respiratory DC migration to the draining lymph nodes, augmented antivirus T cell responses, and diminished lung damage. We also observed similar effects in influenza A virus-infected middle-aged Pla2g2d(-/-) mice. Furthermore, oxidative stress, probably via lipid peroxidation, was found to induce PLA2G2D expression in mice and in human monocyte-derived macrophages. Thus, our results suggest that directed inhibition of a single inducible phospholipase, PLA2G2D, in the lungs of older patients with severe respiratory infections is potentially an attractive therapeutic intervention to restore immune function. </AbstractText>
<CopyrightInformation>© 2015 Vijay et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vijay</LastName>
<ForeName>Rahul</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hua</LastName>
<ForeName>Xiaoyang</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meyerholz</LastName>
<ForeName>David K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo>
<Affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miki</LastName>
<ForeName>Yoshimi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yamamoto</LastName>
<ForeName>Kei</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gelb</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195 Department of Chemistry and Department of Biochemistry, University of Washington, Seattle, WA 98195.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Murakami</LastName>
<ForeName>Makoto</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama 332-0012, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Perlman</LastName>
<ForeName>Stanley</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Interdisciplinary Program in Immunology and Department of Otolaryngology, Department of Pathology, and Department of Microbiology, University of Iowa, Iowa City, IA 52242 Stanley-Perlman@uiowa.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R37 HL036235</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI091322</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI091322</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>AI060699</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 AI060699</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL036235</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK054759</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL36235</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Exp Med</MedlineTA>
<NlmUniqueID>2985109R</NlmUniqueID>
<ISSNLinking>0022-1007</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039521">CD11c Antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.1.4</RegistryNumber>
<NameOfSubstance UI="D054501">Group II Phospholipases A2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Exp Med. 2015 Oct 19;212(11):1755</RefSource>
<PMID Version="1">26482140</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039521" MajorTopicYN="N">CD11c Antigen</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004198" MajorTopicYN="Y">Disease Susceptibility</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054501" MajorTopicYN="N">Group II Phospholipases A2</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>08</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>9</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26392224</ArticleId>
<ArticleId IdType="pii">jem.20150632</ArticleId>
<ArticleId IdType="doi">10.1084/jem.20150632</ArticleId>
<ArticleId IdType="pmc">PMC4612096</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Int J Infect Dis. 2014 Dec;29:301-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25303830</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781533</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2001 May 21;193(10):1135-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11369785</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Chem. 2008 Aug 14;51(15):4708-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18605714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1990 Apr;15(4):129-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2187293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Traffic. 2003 Apr;4(4):214-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12694560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2014 Oct 15;193(8):4235-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25217168</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2011 Dec;121(12):4921-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22105170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2008 Apr 18;133(2):235-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18423196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2012 Nov;86(21):11416-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22915814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Cell. 2005 Feb;97(2):147-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15656780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2008 Jun;172(6):1625-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18467696</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2013 Jun 3;210(6):1217-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23690440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2009 Dec 20;395(2):210-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19853271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2014 Jun 5;510(7503):92-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24899309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2010 Apr;6(4):e1000849</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20386712</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2005 Dec;23(6):649-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16356862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2015 Jun;43(6):1283-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25785521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2009;15(26):3003-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19754376</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2011 Dec 15;184(12):1327-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22174110</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2010 Jul 16;285(29):22202-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20457605</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2000 Jun;908:244-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10911963</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11673-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Immunol. 2005 May;35(5):1491-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15816013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1995;64:653-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7574497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16291-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20805477</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2012 Nov;47(5):688-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22842495</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Proteomics. 2011 Oct 19;74(11):2313-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21718814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2000 Jan 6;403(6765):103-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10638762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1987 Sep 4;237(4819):1171-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2820055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cold Spring Harb Perspect Biol. 2011 Oct;3(10):a004820</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21628428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 May 24;102(21):7671-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15890784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2003 Oct 15;171(8):3936-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14530310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1782-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25810252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2004 Jan;25(1):40-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14698283</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2005 May;6(5):524-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15806106</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Genet. 2014 Dec 04;5:419</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25538730</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12692-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22802632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4844-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10781090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2009 Oct;5(10):e1000636</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19851468</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1995 Aug 11;270(32):18711-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7642515</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2008 May;6(5):363-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18414501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Dec;77(23):12819-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14610203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2012 Jan 1;188(1):21-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22187483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2012 Jan;86(2):884-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22072787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Biol. 2008 Sep 16;6(9):e226</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18798692</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5205-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23479612</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1995 Oct;69(10):6359-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7666537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2012 Jul 15;189(2):1014-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22706082</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2014 Mar 20;40(3):315-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24656045</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Rep. 2012 Jul 26;2(1):136-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22840404</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11375-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9326617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Immunol. 2007;25:443-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17243893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet Pathol. 2013 Nov;50(6):1007-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23558974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):314-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12676807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23891402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Lipid Res. 2004 Feb;45(2):205-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14657205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2002 Oct 21;196(8):1025-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12391014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15577937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2010 Feb;6(2):e1000756</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20140198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2007 Feb 19;204(2):357-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17283205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2012 Aug 15;189(4):1983-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22802419</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2013 Jun;87(12):6551-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23576515</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immun Ageing. 2009 Jul 22;6:10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19624841</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10598-603</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16027362</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2003 Jul 1;171(1):27-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12816979</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Res. 2014 Aug;59(1-3):118-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24845462</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D62 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000D62 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26392224
   |texte=   Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26392224" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021